Skip subpage navigation
COVID-19 is a respiratory disease caused by SARS-CoV-2, a coronavirus discovered in 2019. The virus spreads mainly from person to person through respiratory droplets and small particles produced when an infected person coughs, sneezes, or talks.
- Illness can range from mild to severe, though not everyone infected with the virus develops symptoms.
- Some people are more likely than others to get very sick if they get COVID-19. This includes people who are older, immunocompromised, have certain disabilities or have an underlying health condition.
For more information about COVID-19, please visit the CDC website.
COVID-19 Vaccine
The CDC recommends the 2023-2024 updated COVID-19 vaccines to protect against serious illness from COVID-19.
- Everyone ages 5 years and older should get one dose of an updated COVID-19 vaccine.
- Children aged 6 months to 4 years need multiple doses to be up-to-date, including at least on does of an updated COVID-19 vaccine.
- People who are moderately or severely immunocompromised may get additional doses.
Check with your military hospital or clinic or health care provider for availability and how to schedule an appointment to get the vaccine. For more information about COVID-19 vaccines, please visit the CDC website.
Concerns about the vaccine?
If you have concerns about the COVID-19 vaccine, you may contact the DHA Immunization Healthcare Support Center at 1-877-GET-VACC (1-877-438-8222) option 1 or DSN 761-4245, option 1, if you have questions about the vaccines or about an adverse event after getting the vaccine.
You also may be interested in...
Policy
Dec 31, 2020
.PDF |
129.54 KB
This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DOD Component for executing this guidance, in coordination with the Military Departments and other DOD Components as appropriate.
- Identification #: N/A
- Type: Memorandum
Article
Dec 29, 2020
COVID MTF innovations include more virtual health options and drive thrus.
Article
Dec 28, 2020
Operation Warp Speed has allocated more than 5.9 million doses of the vaccine for jurisdictions to receive in the coming week.
Video
Dec 28, 2020
See how MHS is leading a phased approach to offer 11.1 million Department of Defense personnel the first COVID-19 vaccines. To learn more about the safety and efficacy behind COVID-19 vaccines, go to: https://www.health.mil/Military-Health-Topics/Combat-Support/Public-Health/Coronavirus/COVID-19-Vaccine-Efforts.
Article
Dec 23, 2020
The Military Health System is reviewing how it kept warfighters mission-ready and units online in 2020 during the ongoing pandemic.
Article
Dec 22, 2020
Outstanding efforts recognized during Resiliency Awards
Article
Dec 22, 2020
AFHSD/GEIS continue work with partners across the globe in their efforts to combat COVID-19 and protect military readiness.
Article
Dec 21, 2020
The CDC notes that COVID-19 seems to spread more easily than flu and causes more serious illnesses in some people.
Article
Dec 18, 2020
“In the coming months as the vaccine becomes more widely available, we strongly encourage everyone to get this vaccine,” Place stressed.
Article
Dec 18, 2020
These Guardsmen are trained medics who also took Centers for Disease Control and Prevention courses specific to the coronavirus.
Article
Dec 17, 2020
One way the MHS will provide...improved care is through DoD’s new electronic health record MHS GENESIS, which will continue its rollout through 2023.
Article
Dec 17, 2020
Equipped with lessons learned, BAMC is preparing to shift resources and personnel to ensure hospital readiness in the event of a patient increase.
Article
Dec 17, 2020
[T]he Defense Health Agency’s Immunization Healthcare Division (IHD) is working in collaboration with the CDC to offer the training to the Military Health System’s health care providers.
Policy
Dec 17, 2020
.PDF |
574.09 KB
This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DOD beneficiaries treated at military medical treatment facilities.
- Identification #: N/A
- Type: Memorandum
Article
Dec 16, 2020
While Pfizer’s vaccine is being distributed to all U.S. jurisdictions for administration, several more candidates are in development and clinical trials continue to be conducted simultaneously with pharmaceutical partners.
You are leaving Health.mil
The appearance of hyperlinks does not constitute endorsement by the Department of Defense of non-U.S. Government sites or the information, products, or services contained therein. Although the Defense Health Agency may or may not use these sites as additional distribution channels for Department of Defense information, it does not exercise editorial control over all of the information that you may find at these locations. Such links are provided consistent with the stated purpose of this website.
You are leaving Health.mil
View the external links disclaimer.
Last Updated: February 16, 2024